IAS-USA

@iasusa-official.bsky.social

The IAS–USA has a clearly defined mission and extensive network of experienced and committed experts in the management of HIV and other viral infections, and is recognized for high-quality, independent educational programs.

Registration is open! Clinical decision-makers in Ryan White HIV/AIDS Program (RWHAP)-funded clinics are invited to apply to register for the upcoming RWHAP CLINICAL CONFERENCE. The conference will provide updates on research, care, and treatment issues in the medical management of HIV infection.

Bild

Join the upcoming webinar, Management of Cardiovascular Disease in People With HIV: Insights From the Latest Clinical Data, to explore new guidance on statin use (even in lower-risk patients), the PREVENT risk score, and updated lipid and blood pressure management strategies.

Bild

The US FDA has approved doravirine/islatravir, a once-daily, single-tablet, 2-drug regimen for treatment-experienced adults with suppressed HIV-1. Phase III data show durable 48-week suppression with a favorable safety profile, adding to available treatment options.

We are less than one week away from CROI 2026—bringing together global experts, clinicians, researchers, and advocates to share the latest scientific advances. Join the conversation and share insights throughout the meeting using #CROI2026.

Bild